SCHEMBL55730

SCHEMBL55730

CCNc1cccc(O)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 4/20 0.52
TSHR P16473 3/20 0.52
ALDH1A1 P00352 3/20 0.52
CYP1A2 P05177 2/20 0.52
NLRP3 Q96P20 1/20 0.49
RAPGEF4 Q8WZA2 1/20 0.48
KMT2A Q03164 4/20 0.47
ACHE P22303 3/20 0.47
RECQL P46063 1/20 0.47
HDAC6 Q9UBN7 1/20 0.47
OPRM1 P35372 1/20 0.47
LMNA P02545 2/20 0.46
HSD17B10 Q99714 2/20 0.46
CA12 O43570 1/20 0.46
CA2 P00918 1/20 0.46
CA5A P35218 1/20 0.46
CA9 Q16790 1/20 0.46
CA14 Q9ULX7 1/20 0.46
CA5B Q9Y2D0 1/20 0.46
BLM P54132 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27746749 0.98 CYP3A4 (0.50) CYP3A4TSHRALDH1A1CYP1A2NLRP3
Hydrochloric Acid SCHEMBL3066468 0.98 CYP3A4 (0.50) CYP3A4TSHRALDH1A1CYP1A2NLRP3
Phenol SCHEMBL9774383 0.89 CYP3A4 (0.52) CYP3A4TSHRALDH1A1CYP1A2NLRP3
Pyridine SCHEMBL10748124 0.88 CYP3A4 (0.46) CYP3A4TSHRALDH1A1CYP1A2NLRP3
Metacresol SCHEMBL9329165 0.86 ACHE (0.55) CYP3A4TSHRALDH1A1CYP1A2NLRP3
Formaldehyde SCHEMBL9774387 0.85 RAPGEF4 (0.49) CYP3A4TSHRALDH1A1CYP1A2NLRP3
SCHEMBL3363357 0.84 MAPT (0.50) CYP3A4TSHRALDH1A1CYP1A2KMT2A
SCHEMBL4424661 0.83 ALDH1A1 (0.48) CYP3A4TSHRALDH1A1CYP1A2NLRP3
1-Hydroxy-3-Methoxybenzene SCHEMBL9774366 0.82 MEN1 (0.50) CYP3A4ALDH1A1CYP1A2NLRP3KMT2A
SCHEMBL11508113 0.82 CYP3A4 (0.56) CYP3A4TSHRALDH1A1CYP1A2NLRP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 273 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118929620-A Preparation method of phenolic resin-based hard carbon nanospheres with adjustable particle size and carbon structure 北京化工大学 2024-11-12 CN claimed
CN-110433818-B Nickel molybdate-carbon composite nanosphere, preparation method and application of nickel molybdate-carbon composite nanosphere as electrolytic water hydrogen evolution catalyst 陕西科技大学 2022-02-25 CN claimed
CN-110433818-A A kind of nickel molybdate carbon composite nano ball, preparation method and its application as electrolysis water liberation of hydrogen catalyst UNIV SHAANXI SCIENCE & TECH 2019-11-12 CN claimed
EP-2103299-B1 Oxidizing hair colourant compositions PROCTER & GAMBLE (US) 2013-02-27 EP claimed
CN-101486658-B Preparation method of 3- (N-ethyl-N-isoamyl) aminophenol CONNECT WILSON PENGLAI CHEMICAL CO LTD 2011-11-16 CN claimed
CN-101486658-A Preparation method of 3- (N-ethyl-N-isoamyl) aminophenol CONNECT WILSON PENGLAI CHEMICA (CN) 2009-07-22 CN claimed
CN-1304486-C Phthalocyanine compound, process for producing the same, and optical recording medium containing the same MITSUI CHEMICALS INC (JP) 2007-03-14 CN claimed
WO-2002044284-A1 TRISAZO DYES BASF AKTIENGESELLSCHAFT (DE) 2002-06-06 WO claimed
EP-0645435-B1 Trisazo dye, process for producing the same and aqueous ink composition containing the same ORIENT CHEMICAL IND (JP) 1999-03-24 EP claimed
EP-0645435-A1 Trisazo dye, process for producing the same and aqueous ink composition containing the same ORIENT CHEMICAL INDUSTRIES, LTD. (JP) 1995-03-29 EP claimed
EP-0298704-B1 Adhesive composition for fibrous materials and process of its preparation BRIDGESTONE CORP (JP) 1994-03-23 EP claimed
US-5075415-A ADHESIVE COMPOSITION FOR FIBROUS MATERIALS BASED ON PHENOL-AMINOPHENOL-FORMALDEHYDE CONDENSATION PRODUCTS BRIDGESTONE CORPORATION (JP) 1991-12-24 US claimed
EP-0298704-A2 Adhesive composition for fibrous materials and process of its preparation Bridgestone Corporation (JP) 1989-01-11 EP claimed
JP-3121181-A None JP disclosed
US-20260132123-A1 ABAD INHIBITOR COMPOUNDS UNIV COURT OF THE UNIV OF ST ANDREWS (GB) 2026-05-14 US disclosed
EP-4705297-A1 SMALL MOLECULE THERAPY FOR DUCHENNE MUSCULAR DYSTROPHY THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2026-03-11 EP disclosed
EP-0005451-A2 Process for the manufacture of cationic oxazinic compounds, the oxazinic compounds and their application to the dyeing and printing of textile materials CIBA-GEIGY AG (CH) 1979-11-28 EP disclosed
US-4020084-A Cyclic aminals of aromatic aldehydes BAYER AKTIENGESELLSCHAFT (DT) 1977-04-26 US disclosed
US-4003699-A Oxidation hair dyes based upon tetraaminopyrimidine developers HENKEL & CIE G.M.B.H. (DT) 1977-01-18 US disclosed
US-3996212-A LEUCO DYES FOR PRESSURE SENSITIVE ELEMENTS FUJI PHOTO FILM CO., LTD. (JA) 1976-12-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260132123-A1 ABAD INHIBITOR COMPOUNDS ADH1C, ADH1A, CBR1 CYP3A4 1138/4885TSHR 4420/4885ALDH1A1 52/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.